Buraco macular

Farah, Michel Eid; Moreira Jr., Carlos Augusto; Ávila, Marcos P.

doi:10.5935/0004-2749.19980114

Texto completo disponível apenas em PDF.

REFERÊNCIAS BIBLIOGRÁFICAS

¹
Avila MP, Jalkh AE, Murakamik, Trempe CL, Schepens CL. Biomicroscopic study of the vitreous in macular breaks. Ophthalmology 1983;90:1277-83.
²
Barrie T. Macular holes. Br J Ophthalmol, 1995;79:511-2.
³
De Bustros S. Vitrectomy for prevention of macular holes. results of a randomized multicenter clinical trial. vitrectomy for prevention of macular hole study group. Ophthalmology 1994;101:1055-9.
⁴
Duker JS, Wendel R, Patel AC, Puliafito CA. Late re-opering of macular holes after initially successful treatment with vitreous surgery. Ophthalmology 1994; 101:1373-8.
⁵
Farah ME, Oshima A, Lima ALH. Desaparecimento do buraco macular associado ao desenvolvimento de membrana epiretiniana. Arq Bras Oftal 1993; 56:243-6.
⁶
Freeman WR. Vitrectomy surgery for full-thickness macular holes. Am J Ophthalmol 1993;116:233-5.
⁷
Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment, 2nd ed., St. Louis: The C.V. Mosby, 1997;334.
⁸
Madreperla AS, Geiger GL, Funata M, De La Cruz Z, Green WR. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology, 1994;101:682-6.
⁹
Park SS, Marcus DM, Duker JS, Pesavento RD, Topping TM, Frederick AR. Jr, D'amico DJ. Posterior segment complications after vitrectomy for macular hole. Ophthalmology 1995;102:775-81.
¹⁰
Ruby AJ, Williams DF, Grand MG, Thomas MA, Meredith TA, Boniuk I, Olk RJ. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 1994; 112:359-64.
¹¹
Ryan EA, Lee S, Chern S. Use of intravitreal autologous blood to identify posterior cortical vitreous in macular hole surgery. Arch Ophthalmol 1995; 113:822-3.
¹²
Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 1994;101:1195-200.
¹³
Thompson JT, Hiner CJ, Glaser BM, Gordon AJ, Murphy RP, Sjaarda RN. Fluorescein angiographic characteristics of macular holes before and after vitrectomy with transforming growth factor beta-2. J Ophthalmol 1994; 117:291-301.
¹⁴
West S. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 1995;1119:819.

Datas de Publicação

Publicação nesta coleção
Feb 1998

Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution, que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que o trabalho original seja corretamente citado.

[1] ¹
Avila MP, Jalkh AE, Murakamik, Trempe CL, Schepens CL. Biomicroscopic study of the vitreous in macular breaks. Ophthalmology 1983;90:1277-83.

[2] ²
Barrie T. Macular holes. Br J Ophthalmol, 1995;79:511-2.

[3] ³
De Bustros S. Vitrectomy for prevention of macular holes. results of a randomized multicenter clinical trial. vitrectomy for prevention of macular hole study group. Ophthalmology 1994;101:1055-9.

[4] ⁴
Duker JS, Wendel R, Patel AC, Puliafito CA. Late re-opering of macular holes after initially successful treatment with vitreous surgery. Ophthalmology 1994; 101:1373-8.

[5] ⁵
Farah ME, Oshima A, Lima ALH. Desaparecimento do buraco macular associado ao desenvolvimento de membrana epiretiniana. Arq Bras Oftal 1993; 56:243-6.

[6] ⁶
Freeman WR. Vitrectomy surgery for full-thickness macular holes. Am J Ophthalmol 1993;116:233-5.

[7] ⁷
Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment, 2nd ed., St. Louis: The C.V. Mosby, 1997;334.

[8] ⁸
Madreperla AS, Geiger GL, Funata M, De La Cruz Z, Green WR. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology, 1994;101:682-6.

[9] ⁹
Park SS, Marcus DM, Duker JS, Pesavento RD, Topping TM, Frederick AR. Jr, D'amico DJ. Posterior segment complications after vitrectomy for macular hole. Ophthalmology 1995;102:775-81.

[10] ¹⁰
Ruby AJ, Williams DF, Grand MG, Thomas MA, Meredith TA, Boniuk I, Olk RJ. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 1994; 112:359-64.

[11] ¹¹
Ryan EA, Lee S, Chern S. Use of intravitreal autologous blood to identify posterior cortical vitreous in macular hole surgery. Arch Ophthalmol 1995; 113:822-3.

[12] ¹²
Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 1994;101:1195-200.

[13] ¹³
Thompson JT, Hiner CJ, Glaser BM, Gordon AJ, Murphy RP, Sjaarda RN. Fluorescein angiographic characteristics of macular holes before and after vitrectomy with transforming growth factor beta-2. J Ophthalmol 1994; 117:291-301.

[14] ¹⁴
West S. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 1995;1119:819.

Brasil

Brasil

Buraco macular

Macular hole

REFERÊNCIAS BIBLIOGRÁFICAS

Datas de Publicação